The 3 Dementia Risk Factors You Can Actually Control

Nobody wants to end their life not recognizing the people they love. And yet most of the conversation around dementia sounds like a verdict, not a conversation: genetics, age, bad luck. The implication is that you either dodge it or you don't, and there isn't much to be done either way.

That framing is outdated. A landmark 2024 update from the Lancet Commission on Dementia Prevention identified 45% of all dementia cases as potentially preventable through modifiable risk factors. Nearly half. That's not a footnote — that's a signal that what you do between now and your 80s matters enormously. The question isn't whether lifestyle affects brain aging. It's which levers are actually worth pulling.

This article breaks down the three modifiable risk factors most strongly linked to dementia-free longevity, what the science actually says about each, and how to start acting on them in a way that's grounded in evidence rather than wellness optimism.

What Are Dementia Prevention Risk Factors, Really?

A "modifiable risk factor" sounds clinical, but the concept is simple: it's a thing you can change. Not all dementia risk is modifiable — your age, your APOE4 gene status, and your family history are what they are. But modifiable factors are the variables where intervention research actually shows a signal in humans, not just mice.

The 2024 Lancet Commission expanded its original 2020 list to 14 modifiable factors, including high LDL cholesterol (new addition), untreated vision loss, and social isolation. But three factors consistently sit at the top of the evidence hierarchy when ranked by population-level impact and by the quality of the research behind them: cardiovascular health, metabolic health, and sleep quality. These aren't random picks from a wellness listicle. They're the factors with the most coherent mechanistic explanation, the most replicable human data, and the most actionable clinical pathways.

Dementia Prevention Risk Factor #1: Cardiovascular Health

Your brain is a vascular organ first

Here's something that gets lost in the Alzheimer's conversation: your brain runs on blood. It consumes roughly 20% of your body's oxygen and glucose despite being only 2% of your body weight. Every beat of your heart is delivering fuel and clearing waste from 86 billion neurons. When the pipes start to narrow or stiffen, the brain is one of the first places to show it.

Vascular dementia is the second most common form of dementia after Alzheimer's, but the two are more intertwined than the labels suggest. Autopsy studies consistently find that people diagnosed with Alzheimer's during their lifetime also had significant vascular damage. The current thinking is that cardiovascular dysfunction doesn't just cause one type of dementia — it accelerates the progression of all of them.

What the evidence shows

The data here is some of the most robust in the entire field:

• Midlife hypertension (systolic blood pressure above 130 mmHg) is associated with roughly a 60% increased risk of dementia in later life, according to a 2019 meta-analysis of over 2 million participants. The key word is "midlife" — the damage accumulates decades before symptoms appear.
• High LDL cholesterol in midlife, newly added to the 2024 Lancet list, is associated with increased amyloid deposition in the brain — the protein plaques associated with Alzheimer's disease.
• Atrial fibrillation doubles dementia risk, likely because it generates microemboli (tiny clots) that cause small strokes throughout the brain — the kind you'd never notice one at a time.
• The SPRINT MIND trial, a major randomized controlled trial published in JAMA, found that intensive blood pressure control (targeting below 120 mmHg systolic) reduced probable mild cognitive impairment by 19% compared to standard treatment.

This is not mechanistic reasoning or mouse data. This is human trial evidence that treating cardiovascular risk reduces brain risk. That matters.

What you can do

Know your numbers. Specifically: blood pressure, fasting lipids, and resting heart rate. If your LDL is drifting above 100 mg/dL in midlife, that's not something to watch — it's something to address. Same with blood pressure creeping into the 130s. These aren't just heart problems. They're brain problems on a 20-year delay.

Dementia Prevention Risk Factor #2: Metabolic Health

The brain-insulin connection nobody told you about

Ready for a reframe? Alzheimer's disease is sometimes called "Type 3 diabetes" in research circles. That's not an official diagnosis, and the analogy isn't perfect, but it captures something real: the brain depends on insulin signaling to regulate glucose metabolism, and when that signaling breaks down, neurons start to starve.

Your brain has its own insulin receptors. They regulate synaptic function, neuronal growth, and the clearance of amyloid plaques. When those receptors become resistant to insulin — the same process that underpins Type 2 diabetes — the brain struggles to use glucose efficiently. Neurons under chronic energy stress are neurons that age faster, accumulate damage faster, and die faster.

What the evidence shows

• People with Type 2 diabetes have roughly double the risk of Alzheimer's disease compared to those without it, based on multiple large prospective cohort studies.
• Hyperglycemia (chronically high blood sugar, even below the diabetes threshold) is independently associated with increased dementia risk. A large study in the New England Journal of Medicine found that higher average glucose levels were associated with higher dementia risk even in people without diabetes.
• Obesity in midlife is associated with a 33% increase in dementia risk per the 2024 Lancet report, partially mediated through insulin resistance and systemic inflammation.
• Metformin, the most prescribed diabetes drug in the world, has shown associations with reduced dementia risk in observational studies, though randomized trial data in non-diabetic populations is still pending.

The mechanism matters here. High glucose promotes advanced glycation end-products (AGEs) — think of them as a kind of biological rust — which damage blood vessels and neurons alike. It also drives neuroinflammation, another key accelerator of cognitive decline.

What you can do

Metabolic health isn't just your fasting glucose. It's your post-meal glucose spikes, your insulin sensitivity, your visceral fat, and your HbA1c (a 3-month average of your blood sugar). Most people don't know their post-meal glucose numbers, because they've never worn a continuous glucose monitor. That gap in self-knowledge is fixable. So is the metabolic dysfunction driving it, through targeted dietary changes, exercise, weight management, and in some cases, medically supervised metabolic therapies.

Dementia Prevention Risk Factor #3: Sleep Quality

Your brain has a cleaning crew. They work the night shift.

This might be the most underappreciated mechanism in all of brain aging. In 2013, researchers at the University of Rochester discovered something genuinely surprising: the brain has its own waste-clearance system, called the glymphatic system. During deep sleep, the brain's cells shrink by about 60%, allowing cerebrospinal fluid to flush through and clear out metabolic waste — including amyloid beta and tau proteins, the very molecules that accumulate in Alzheimer's disease.

The glymphatic system is almost entirely inactive when you're awake. It runs on night-shift hours. And if you're consistently sleeping less than 7 hours, or your sleep architecture is disrupted (meaning you're not getting enough deep, slow-wave sleep), the cleaning crew keeps getting sent home early.

What the evidence shows

• A 2021 study in Nature Communications found that consistently sleeping 6 hours or less per night at age 50 was associated with a 30% increased risk of dementia over the following 25 years, even after controlling for mental health and cardiovascular conditions.
• People with obstructive sleep apnea (OSA) have significantly higher rates of amyloid accumulation in the brain. A 2017 study in JAMA Neurology found that OSA was associated with earlier onset of mild cognitive impairment by roughly 10 years.
• Even a single night of sleep deprivation produces a measurable increase in amyloid beta concentration in the human brain, as shown in a 2017 PNAS study. Imagine what years of chronic short sleep does.
• The relationship appears to be U-shaped: both short sleep (under 6 hours) and long sleep (over 9 hours) are associated with higher dementia risk, though the long-sleep association likely reflects reverse causation (early neurodegeneration disrupts sleep regulation).

What you can do

Start with the basics that actually have evidence behind them: consistent sleep and wake times, cool and dark sleeping environment, alcohol restriction (alcohol fragments sleep architecture even when it makes you feel drowsy), and no screens in the last 30-60 minutes before bed. If you snore, wake up tired regardless of hours slept, or have been told you stop breathing in your sleep, get evaluated for sleep apnea. This is not optional. Untreated OSA is one of the most correctable dementia risk factors on the list, and most people with it have never been diagnosed.

The Reality Check: What This Evidence Can and Can't Tell You

It's worth being honest about the limits here. Most of the strongest data linking these factors to dementia risk is observational — meaning researchers tracked large populations over decades and looked at who developed dementia. That design is excellent for identifying associations, but it can't fully prove causation. The body is complicated, and people who have good metabolic health also tend to exercise, eat well, and have higher socioeconomic status, all of which are independently protective.

What we have from randomized trials — SPRINT MIND being the clearest example — is real but limited in scope. We don't yet have a randomized trial showing that fixing your sleep or optimizing your glucose for 20 years prevents dementia. We probably never will, because those trials are impossible to run.

What we have is mechanistic coherence (we understand why these things damage the brain), consistent observational signals across populations, and a growing body of intervention data that lines up with the theory. That's enough to act on. It's not enough to claim certainty.

The honest answer is: we don't know exactly how much risk reduction you'll get. But the interventions are low-risk, broadly beneficial, and supported by the best evidence we have. That's a reasonable basis for action.

Who Should Be Thinking About This Now?

The honest answer: anyone over 40. The pathological changes associated with Alzheimer's begin 15-20 years before symptoms. By the time memory problems are noticeable, the window for primary prevention has largely closed. This is a midlife problem that masquerades as an old-age problem.

You should pay particular attention if you:

• Have a first-degree relative with Alzheimer's or vascular dementia
• Carry the APOE4 genetic variant (a known risk modifier)
• Have been diagnosed with hypertension, prediabetes, Type 2 diabetes, or metabolic syndrome
• Sleep fewer than 7 hours most nights, or have never been screened for sleep apnea
• Have LDL above 130 mg/dL in your 40s or 50s
• Are postmenopausal (estrogen decline accelerates cardiovascular and metabolic risk simultaneously)

None of these factors sentences you to dementia. But each one is a reason to get your numbers in front of a clinician who takes longevity seriously.

Risks of Ignoring the Data

The risks here aren't of doing something — they're of waiting. The main cost of acting on these risk factors is effort: improving your diet, exercising more consistently, prioritizing sleep, and managing your metabolic and cardiovascular numbers. The cost of not acting is decades of cumulative damage to a brain that doesn't send you a warning sign until it's already significantly compromised.

If you're using medications or supplements to address metabolic risk (metformin for insulin sensitivity, for example), it's worth knowing those come with their own considerations:

• Metformin can deplete B12 over time — monitoring is important
• Blood pressure medications, while effective, need to be matched to your specific physiology
• GLP-1 receptor agonists for weight and metabolic management have GI side effects that resolve with proper dose titration

The point isn't to avoid intervention. It's to do it with someone who's actually tracking your labs and adjusting based on what they show.

How to Get Started: The Healthspan Approach to Cognitive Longevity

Knowing the three factors is one thing. Getting a clinical plan built around your actual numbers is another. This is where most people stall: they read the research, feel motivated for a week, and then don't know what to do with their last blood panel from three years ago.

Longevity Optimization at Healthspan is designed exactly for this gap. It's a medically supervised protocol that starts with comprehensive labs — cardiovascular biomarkers, metabolic markers including fasting glucose, HbA1c, insulin, and lipids, plus inflammatory markers and hormonal baselines — and then builds a clinical plan around what your numbers actually show, not what a generic wellness guide says.

If your metabolic picture shows early insulin resistance or elevated post-meal glucose, the CGM Metabolic Protocol gives you real-time visibility into your blood sugar patterns using a continuous glucose monitor, paired with clinical interpretation and actionable guidance. For people further along the metabolic risk spectrum, Metformin is available as part of a supervised protocol with ongoing monitoring.

The consultations aren't one-and-done. Healthspan physicians review your labs, adjust your protocol as your biomarkers shift, and flag the things your annual physical probably skips entirely. That's the clinical supervision that separates a coherent prevention strategy from a stack of supplements you found on Reddit.

If protecting your brain for the next 30 years sounds worth a conversation, start with your labs.

Frequently Asked Questions About Dementia Prevention Risk Factors

What are the most important modifiable dementia risk factors?

The 2024 Lancet Commission identified 14 modifiable dementia risk factors. The three with the strongest evidence for population-level impact are cardiovascular health (especially blood pressure and LDL cholesterol), metabolic health (particularly insulin resistance and blood sugar dysregulation), and sleep quality, including untreated sleep apnea. Together, these factors are estimated to account for a substantial portion of the preventable fraction of dementia cases.

Can you actually prevent dementia, or just delay it?

Honest answer: probably a mix of both. The 2024 Lancet Commission estimates up to 45% of dementia cases could be delayed or prevented by addressing modifiable risk factors. The word "prevented" in research language often means "delayed onset significantly" rather than "eliminated entirely." Even delaying dementia onset by 5 years would roughly halve its prevalence at the population level. That's meaningful, even if it's not a cure.

At what age should I start worrying about dementia prevention?

Your 40s and 50s, at the latest. The pathological changes associated with Alzheimer's disease — amyloid plaques and tau tangles — begin accumulating 15 to 20 years before any symptoms appear. That means midlife is the primary prevention window. Waiting until memory problems emerge means the biology has already had decades of head start.

Does sleep really affect dementia risk?

Yes, and the mechanism is unusually well understood. The brain's glymphatic system clears amyloid beta and tau proteins primarily during deep sleep. Consistently sleeping 6 hours or less at age 50 is associated with a 30% increased risk of dementia over the following 25 years. Untreated obstructive sleep apnea, which fragments sleep architecture, is associated with earlier cognitive decline by roughly 10 years. Sleep isn't optional maintenance. It's active brain cleaning.

How does blood sugar affect Alzheimer's risk?

The brain has its own insulin receptors and depends on insulin signaling to regulate glucose metabolism. When those receptors become insulin-resistant, neurons struggle to access energy efficiently. This is why some researchers call Alzheimer's "Type 3 diabetes." People with Type 2 diabetes have roughly double the risk of Alzheimer's. Even elevated glucose below the diabetes threshold is independently associated with higher dementia risk in large prospective studies.

Can metformin help prevent dementia?

The evidence is promising but not yet definitive. Observational studies have found associations between metformin use and lower dementia incidence in people with diabetes. The proposed mechanisms are plausible: metformin improves insulin sensitivity, reduces systemic inflammation, and activates AMPK pathways involved in cellular health. Randomized controlled trials in non-diabetic populations are ongoing. Right now, the evidence justifies clinical consideration for high-risk individuals, not a universal recommendation.

What blood tests should I get to assess my dementia risk?

No single test predicts dementia, but a comprehensive panel gives you a picture of your modifiable risk. Key markers include: blood pressure, fasting glucose, HbA1c, fasting insulin, lipid panel (total cholesterol, LDL, HDL, triglycerides), hs-CRP (inflammation), and homocysteine (a vascular risk marker often missed on standard panels). APOE4 genetic testing is available but requires careful context from a clinician familiar with how to interpret and act on it.